Nonsedative regimens in the treatment of epilepsy.
Trends in the diagnosis of epilepsy have continued to focus on the fundamental cause of the seizures, as well as the seizure type. It is the latter that determines symptomatic therapy. New drugs have improved the lives of many epileptic patients, and emphasis on nonsedative medications, both new and old, is now possible and desirable in most patients. Finally, new and better drugs are needed for the many severely affected epileptic patients who are not helped by the currently available antiepileptic drugs.
D002220:Carbamazepine / Q000009:adverse effects / Q000627:therapeutic use*; D004827:Epilepsy / Q000188:drug therapy*; D005013:Ethosuximide / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use*; D012640:Seizures / Q000175:diagnosis / Q000209:etiology; D014635:Valproic Acid / Q000009:adverse effects / Q000627:therapeutic use*
D002220:Carbamazepine; D005013:Ethosuximide; D014635:Valproic Acid; D010672:Phenytoin